Primrose Bio presents at the mRNA-Based Therapeutics Summit 2025: Enhancing RNA Polymerase Performance

September 12, 2025

Primrose Bio is participating in the 4th Annual mRNA-Based Therapeutics Summit, part of the World RNA Events Series by Hanson Wade, taking place September 23–25 in Boston, MA.

On Day 2, Patrik Engström, PhD, presents at 11:30 AM on:
“Engineered RNA Polymerases to Manufacture mRNA with High Yields, High Quality, and Efficient Capping.”

In his session, Engström discusses:

  • How to increase mRNA yield and capping efficiency while minimizing impurities
  • The use of molecular evolution to tailor enzymes for a variety of templates, cap analogs, and modified nucleotides in mRNA manufacturing
  • Strategies for lowering production costs with improved polymerase efficiency
  • Scaling enzyme manufacturing with Pfenex Expression Technology® for consistent, high-quality results

Patrik Engström, PhD also presents a scientific poster titled “Advancing mRNA Therapeutics with High-Performance RNA Polymerases,” showcasing recent data from our Prima RNApols™ platform.

Subscribe to our Newsletter